• 3rd Annual NPC Pandemic and Biosecurity Forum

    National Press Club 529 14th Street NW, Washington, DC, United States

    The Scowcroft Institute of International Affairs at the Bush School of Government and Public Service presents the Third Annual Pandemic & Biosecurity Policy Summit on 14 May 2019 at the National Press Club in Washington, D.C. The discussion will address the 100th anniversary of the 1918-19 influenza outbreak and consider global health security challenges of

  • NIAID Small Business Workshop – Los Angeles

    California NanoSystems Institute at UCLA 570 Westwood Plaza, Los Angeles, United States

    The National Institute of Allergy and Infectious Diseases (NIAID) SBIR/STTR Small Business Workshop 2019 will take place 15-16 May 2019 in Los Angeles, California. Biotechnology entrepreneurs, faculty members, postdoctoral fellows, and interested innovators starting a new enterprise can learn about NIH-supported entrepreneurship opportunities, writing successful grant applications, and NIH SBIR/STTR policies and regulations. The purpose

  • Emerging Infectious Diseases of Wildlife: A Biosecurity Threat

    Medimmune One Medimmune Way, Gaithersburg, MD, United States

    A ChABSA Technical Seminar will be held in Gaithersburg MD and by webcast on 15 May 2019 on Emerging Infectious Diseases of Wildlife: A Biosecurity Threat. Speaker Bio Dr. Karen Lips, Professor of Biology at the University of Maryland is the presenter. She has a B.S. in Zoology from the University of South Florida, and

  • DARPA ReVector Proposers Day

    Executive Conference Center (ECC) 4075 Wilson Boulevard, Arlington, VA, United States

    The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is holding a Proposers Day meeting on 17 May 2019 to provide information to potential proposers on the objectives of the new ReVector program and to facilitate teaming. The goal of ReVector is to develop an easily delivered treatment — for example, a topical solution

  • RFI Deadline – Malaria Prophylactic Drug Tafenoquine

    Global Biodefense Calendar

    The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick, MD, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. The operational testing will look at the drug’s performance attributes and usability. The DoD is seeking sources, capability statements, and industry feedback

  • Cross-Sector Collaboration to Implement Health in All Policies (HiAP)

    Online

    NACCHO is hosting a Health in All Policies (HiAP) webinar series for local health departments. The goal of the webinar series is to provide an open, informal space for dialogue and peer-to-peer sharing about challenges and best practices. The webinars take place on the second Wednesday of the month, and each month has a different

  • Biodefense World Summit 2019

    Hyatt Regency Bethesda One Bethesda Metro Center, Bethesda, MD, United States

    Cambridge Healthtech Institute's (CHI) 5th Annual Biodefense World Summit 2019 is a dynamic conference for the entire biodefense community: technology providers to policy makers at industry, government and academic institutions. The event will be held on June 17-19, 2019 at the Hyatt Regency in Bethesda, MD. Conferences: Biodetection Technologies: Biothreat and Pathogen Detection Biodetection Technologies:

  • Webinar: Local Health Department Role in Containment of Novel Resistance

    Webinar

    As issues with drug resistant pathogens have emerged across the country, local health departments have been called on to lead and support the containment of novel or targeted multidrug-resistant organisms (MDROs). Join NACCHO to learn more about the experiences of three local health departments who have been affected by containment events. By the end of

  • CDC RFI Deadline: Rapid Response to Outbreaks for Sample Collection

    Global Biodefense Calendar

    CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency, obtain informed consent, collect specimens (blood, urine, swabs, etc.) from identified patients, and safely ship these specimens to CDC in accordance with all applicable local, state,